1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6613025AD26B4B0A500258C75002E2B97
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-disease-awareness-program-immunology-structure-timing?opendocument
18
19opendocument
2018.97.14.81
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Product Launch » Influences on Market Entry

Disease Awareness Program Excellence in Immunology: Structure and Timing

ID: 5875


Features:

4 Info Graphics

13 Data Graphics

280+ Metrics

3 Narratives


Pages/Slides: 24


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Disease Awareness Program Excellence in Immunology: Structure and Timing”

STUDY OVERVIEW

Immunologic diseases often span multiple specialties and pose significant challenges for early detection and diagnosis. To effectively educate the healthcare ecosystem and raise visibility around complex, systemic conditions, disease awareness efforts must be strategically structured and precisely timed to align with market readiness.

Best Practices, LLC conducted this benchmarking study to explore how immunology-focused companies are building impactful awareness campaigns. This study provides proven structural models, timing frameworks, and tactical insights to support successful program planning and deployment.


KEY TOPICS

  • Immunology Disease Awareness Program Structure
  • Disease Awareness Tactics
  • Timing of Disease Awareness Activities

KEY METRICS

  • Organizational structure of immunology disease awareness programs – Total benchmark class, large vs. mid-small pharma; global vs. country level; single brand vs. portfolio
  • Functional leadership and cross-team collaboration in immunology disease awareness programs
  • Prevalence of dedicated immunology disease awareness teams
  • Initiation and conclusion points of immunology disease awareness resourcing – Total benchmark class, large vs. mid-small pharma; global vs. country level; single brand vs. portfolio; highly competitive vs. less competitive market
  • Timing and utilization of immunology disease awareness activities
  • Most frequent immunology disease awareness activities

SAMPLE KEY FINDINGS

  • Disease Awareness Activities: Unbranded websites, Disease state presentations and MSL presentations are the most utilized disease awareness activities.

METHODOLOGY

Best Practices, LLC engaged 5 leaders from 5 life sciences organizations focused on immunology therapies in this benchmarking research. Alongside primary research, in-depth operational interviews were conducted with select executives. Relevant secondary research is incorporated to further provide context.

Industries Profiled:
Pharmaceutical; Diagnostic


Companies Profiled:
AbbVie; Prometheus Laboratories; PruGen Pharmaceuticals; Teva Pharmaceuticals; Tokai Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.